27502245|t|Cartilage inflammation and degeneration is enhanced by pro-inflammatory (M1) macrophages in vitro, but not inhibited directly by anti-inflammatory (M2) macrophages
27502245|a|Macrophages play a crucial role in the progression of osteoarthritis (OA). Their phenotype may range from pro-inflammatory to anti-inflammatory. The aim of this study was to evaluate the direct effects of macrophage subtypes on cartilage by culturing macrophage conditioned medium (MCM) on human articular cartilage. Human OA cartilage explants were cultured with MCM of pro-inflammatory M (IFNγ + TNFα), or anti-inflammatory M (IL-4) or M (IL-10) human monocyte-derived macrophages. To assess effects of anti-inflammatory macrophages, the cartilage was cultured with a combination of MCM phenotypes as well as pre-stimulated with IFNγ + TNFα cartilage before culture with MCM. The reactions of the explants were assessed by gene expression, nitric oxide (NO) production and release of glycosaminoglycans (GAGs). M (IFNγ + TNFα) MCM affected OA cartilage by upregulation of IL1B (Interleukin 1β), IL6, MMP13 (Matrix Metalloproteinase-13) and ADAMTS5 (A Disintegrin And Metalloproteinase with Thrombospondin Motifs-5), while inhibiting ACAN (aggrecan) and COL2A1 (collagen type II). M (IL-10) upregulated IL1B and Suppressor of cytokine signaling 1 (SOCS1). NO production and GAG release by the cartilage was increased when cultured with M (IFNγ + TNFα) MCM. M (IL-4) and M (IL-10) did not inhibit the effects of M (IFNγ + TNFα) MCM of neither phenotype affected IFNγ + TNFα pre-stimulated cartilage, in which an inflammatory gene response was deliberately induced. M (IFNγ + TNFα) macrophages have a prominent direct effect on OA cartilage, while M (IL-4) and M (IL-10) do not inhibit the effects of M (IFNγ + TNFα), or IFN γ+ TNFα induced inflammation of the cartilage. Therapies aiming at inhibiting cartilage degeneration may take this into account by directing suppression of pro-inflammatory macrophages or stimulation of anti-inflammatory macrophages.
27502245	0	22	Cartilage inflammation	T047	C0008439
27502245	27	39	degeneration	T046	C1285228
27502245	43	51	enhanced	T052	C2349975
27502245	55	71	pro-inflammatory	T169	C0333348
27502245	72	88	(M1) macrophages	T025	C0024432
27502245	89	97	in vitro	T080	C1533691
27502245	107	116	inhibited	T080	C0311403
27502245	117	125	directly	T080	C1947931
27502245	129	146	anti-inflammatory	T080	C1515999
27502245	147	163	(M2) macrophages	T025	C4086555
27502245	164	175	Macrophages	T025	C0024432
27502245	203	214	progression	T169	C0449258
27502245	218	232	osteoarthritis	T047	C0029408
27502245	234	236	OA	T047	C0029408
27502245	245	254	phenotype	T032	C0031437
27502245	270	286	pro-inflammatory	T169	C0333348
27502245	290	307	anti-inflammatory	T080	C1515999
27502245	351	357	direct	T080	C1947931
27502245	358	368	effects of	T080	C1704420
27502245	369	379	macrophage	T025	C0024432
27502245	380	388	subtypes	T185	C0449560
27502245	392	401	cartilage	T024	C0007301
27502245	405	414	culturing	T059	C0430400
27502245	415	425	macrophage	T025	C0024432
27502245	426	444	conditioned medium	T130	C0162518
27502245	446	449	MCM	T130	C0162518
27502245	454	459	human	T016	C0086418
27502245	460	479	articular cartilage	T024	C0007303
27502245	481	486	Human	T016	C0086418
27502245	487	489	OA	T047	C0029408
27502245	490	499	cartilage	T024	C0007301
27502245	500	508	explants	T061	C0444933
27502245	514	522	cultured	T059	C0430400
27502245	528	531	MCM	T130	C0162518
27502245	535	553	pro-inflammatory M	T025	C0024432
27502245	555	559	IFNγ	T116,T121,T129	C0021745
27502245	562	566	TNFα	T116,T129	C1456820
27502245	572	591	anti-inflammatory M	T025	C0024432
27502245	593	598	IL-4)	T116,T129	C0021758
27502245	602	603	M	T025	C0024432
27502245	605	610	IL-10	T116,T129	C0085295
27502245	612	617	human	T016	C0086418
27502245	618	646	monocyte-derived macrophages	T025	C0024432
27502245	651	657	assess	T052	C1516048
27502245	658	668	effects of	T080	C1704420
27502245	669	698	anti-inflammatory macrophages	T025	C0024432
27502245	704	713	cartilage	T024	C0007301
27502245	718	726	cultured	T059	C0430400
27502245	734	745	combination	T080	C0205195
27502245	749	752	MCM	T130	C0162518
27502245	753	763	phenotypes	T032	C0031437
27502245	775	789	pre-stimulated	T070	C1948023
27502245	795	799	IFNγ	T116,T121,T129	C0021745
27502245	802	806	TNFα	T116,T129	C1456820
27502245	807	816	cartilage	T024	C0007301
27502245	824	831	culture	T059	C0430400
27502245	837	840	MCM	T130	C0162518
27502245	877	885	assessed	T052	C1516048
27502245	889	904	gene expression	T045	C0017262
27502245	906	934	nitric oxide (NO) production	T038	C3155545
27502245	939	946	release	T169	C1283071
27502245	950	968	glycosaminoglycans	T109,T121,T123	C0017973
27502245	970	974	GAGs	T109,T121,T123	C0017973
27502245	977	978	M	T025	C0024432
27502245	980	984	IFNγ	T116,T121,T129	C0021745
27502245	987	991	TNFα	T116,T129	C1456820
27502245	993	996	MCM	T130	C0162518
27502245	1006	1008	OA	T047	C0029408
27502245	1009	1018	cartilage	T024	C0007301
27502245	1022	1034	upregulation	T044	C0041904
27502245	1038	1042	IL1B	T116,T129	C0021753
27502245	1044	1058	Interleukin 1β	T116,T129	C0021753
27502245	1061	1064	IL6	T116,T129	C0021760
27502245	1066	1071	MMP13	T116,T126	C0255672
27502245	1073	1100	Matrix Metalloproteinase-13	T116,T126	C0255672
27502245	1106	1113	ADAMTS5	T116,T126	C4255122
27502245	1115	1179	A Disintegrin And Metalloproteinase with Thrombospondin Motifs-5	T116,T126	C4255122
27502245	1188	1198	inhibiting	T052	C3463820
27502245	1199	1203	ACAN	T116,T123	C1429453
27502245	1205	1213	aggrecan	T116,T123	C1429453
27502245	1219	1225	COL2A1	T116,T123	C1505419
27502245	1227	1243	collagen type II	T116,T123	C1505419
27502245	1246	1247	M	T025	C0024432
27502245	1249	1254	IL-10	T116,T129	C0085295
27502245	1256	1267	upregulated	T044	C0041904
27502245	1268	1272	IL1B	T116,T129	C0021753
27502245	1277	1311	Suppressor of cytokine signaling 1	T116	C3275256
27502245	1313	1318	SOCS1	T116	C3275256
27502245	1321	1334	NO production	T038	C3155545
27502245	1339	1342	GAG	T109,T121,T123	C0017973
27502245	1343	1350	release	T169	C1283071
27502245	1358	1367	cartilage	T024	C0007301
27502245	1372	1381	increased	T081	C0205217
27502245	1387	1395	cultured	T059	C0430400
27502245	1401	1402	M	T025	C0024432
27502245	1404	1408	IFNγ	T116,T121,T129	C0021745
27502245	1411	1415	TNFα	T116,T129	C1456820
27502245	1417	1420	MCM	T130	C0162518
27502245	1422	1423	M	T025	C0024432
27502245	1425	1430	IL-4)	T116,T129	C0021758
27502245	1435	1436	M	T025	C0024432
27502245	1438	1444	IL-10)	T116,T129	C0085295
27502245	1453	1460	inhibit	T052	C3463820
27502245	1465	1475	effects of	T080	C1704420
27502245	1476	1477	M	T025	C0024432
27502245	1479	1483	IFNγ	T116,T121,T129	C0021745
27502245	1486	1490	TNFα	T116,T129	C1456820
27502245	1492	1495	MCM	T130	C0162518
27502245	1507	1516	phenotype	T032	C0031437
27502245	1517	1525	affected	T169	C0392760
27502245	1526	1530	IFNγ	T116,T121,T129	C0021745
27502245	1533	1537	TNFα	T116,T129	C1456820
27502245	1538	1552	pre-stimulated	T070	C1948023
27502245	1553	1562	cartilage	T024	C0007301
27502245	1576	1593	inflammatory gene	T028	C0017337
27502245	1594	1602	response	T032	C0871261
27502245	1607	1619	deliberately	T080	C0205556
27502245	1620	1627	induced	T169	C0205263
27502245	1629	1630	M	T025	C0024432
27502245	1632	1636	IFNγ	T116,T121,T129	C0021745
27502245	1639	1643	TNFα	T116,T129	C1456820
27502245	1645	1656	macrophages	T025	C0024432
27502245	1664	1673	prominent	T080	C0205402
27502245	1674	1680	direct	T080	C1947931
27502245	1681	1687	effect	T080	C1280500
27502245	1691	1693	OA	T047	C0029408
27502245	1694	1703	cartilage	T024	C0007301
27502245	1711	1712	M	T025	C0024432
27502245	1714	1719	IL-4)	T116,T129	C0021758
27502245	1724	1725	M	T025	C0024432
27502245	1727	1733	IL-10)	T116,T129	C0085295
27502245	1741	1748	inhibit	T052	C3463820
27502245	1753	1763	effects of	T080	C1704420
27502245	1764	1765	M	T025	C0024432
27502245	1767	1771	IFNγ	T116,T121,T129	C0021745
27502245	1774	1778	TNFα	T116,T129	C1456820
27502245	1784	1787	IFN	T116,T121,T129	C0021745
27502245	1791	1795	TNFα	T116,T129	C1456820
27502245	1796	1803	induced	T169	C0205263
27502245	1804	1816	inflammation	T046	C0021368
27502245	1824	1833	cartilage	T024	C0007301
27502245	1835	1844	Therapies	T061	C0087111
27502245	1855	1865	inhibiting	T052	C3463820
27502245	1866	1888	cartilage degeneration	T046	C1285228
27502245	1929	1940	suppression	T045	C0038855
27502245	1944	1972	pro-inflammatory macrophages	T025	C0024432
27502245	1976	1987	stimulation	T070	C1948023
27502245	1991	2020	anti-inflammatory macrophages	T025	C0024432